US-EN
Select Country
<br/>A broad range of imaging agents, procedures and devices that meet emerging medical challenges and facilitate clinical success <br/>One of the World's leading companies engaged in the development of new imaging solutions that address the evolving needs of patients <br/>Continuously invest in medical research and development, to provide innovative diagnostic products that match patients' needs <br/>A global partner with local resources. Everyday Bracco moves forward in all key diagnostic imaging modalities
1 2 3 4

Latest news

Bracco Diagnostics Inc. receives U.S. FDA Approval for new Ultrasound Contrast Agent

Lumason™ (sulfur hexafluoride lipid-type A microspheres) for injectable suspension, now available for use in adults with suboptimal echocardiograms.

Press release

 

Video

Bracco Diagnostics Inc. Launches the New CardioGen-82® (Rubidium Rb 82 Generator) Website with Superior Resources

Bracco Diagnostics Inc. announced the launch of a new website for CardioGen-82 (http://www.cardiogen.com) with additional resources for healthcare providers to improve their use of cardiac positron emission tomography (PET) myocardial perfusion imaging (MPI).

Press release

Congress calendar

From October 17 to 22, 2014
Philadelphia, PA

ACG

From November 20 to 22, 2014
Orlando, FL

ASHA

Educational Events

AIMS

Established to compare various clinical approaches for targeted diagnostic imaging.

Read more

BAMRIS

Designed to help physicians stay abreast of the latest changes and applications in magnetic resonance.

Read more